Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

McAfee (MFE): Bullish sentiment, poor stock performance

Shares of security software concern McAfee Inc. ( NYSE: MFE , Stock Forum ) have been far from impressive this year. The stock has underperformed the struggling S&P 500 Index (SPX) by roughly 17% on a relative-strength basis during the past 60 trading days. What's more, M...
Joseph Hargett | October 28, 2012 |

Correction in Digital Marketing Sector Valuations Creates an Attractive Entry Point for Long-term In

(Click to read report.) Research Capital Corp. is – Initiating Coverage with a BUY Rating and Target Price of $2.20 (USD) on Logiq Inc. ( NEO: LGIQ , OTCQX: LGIQ , Forum ) Logiq’s Presence in Two Large and Growing Segments of Digital Marketing ...
Featured Submission | March 31, 2022 |

The Golden Bullet for Drug Delivery

It’s the Holy Grail in the cannabis industry. Everyone is trying to innovate the best delivery system to optimize the “bioavailability” (uptake) of medical cannabis in order to offer the perfect pairing -- precise dosing with a fast on...
Marc Davis | January 8, 2020 |

Growing inequality threatens mining

In the 1986 classic ‘Platoon’, Charlie Sheen’s character Chris Taylor tells everyone that he dropped out of college to serve in the Vietnam War. This sets him apart from the other grunts and makes Taylor seem noble and patriotic, giving up sch...
Richard (Rick) Mills | November 29, 2019 |

Jan 31st 2020, Crypto Chartbook – Turning point entry timing

Turning point entry timing A turning point in most cases isn’t evolving from a down to up price movement. There is a sideways period, an entry zone rather than a specific price. Prices meander around for a period of time. It is obvious that, just because a...
Korbinian Koller | January 31, 2020 |

Silver Poised for a Breakout

Technical analyst Clive Maund discusses why he believes silver is amazingly cheap and a sure sign that a major precious metals sector bull market is starting. We have already been over the reasons why a major precious metals (PM) sector bull market is st...
Streetwise Reports | July 3, 2019 |

Silver Should Pause At $16.75 Before Next Rally Starts

Our advanced Fibonacci price modeling system is suggesting that the current Silver rally may be nearing a point where the price will pause and retrace a bit before advancing further. The incredible breakout rally over the past few weeks in Silver was a real surprise for many i...
Chris Vermeulen | July 25, 2019 |

The Barriers to Investing in Private Equity Are Too High

The rich are getting richer and the poor are getting poorer, and for that we can largely blame policies of envy that increasingly restrict investors’ access to wealth-building instruments. Case in point: I was recently invited to participate in a pri...
Frank Holmes | October 15, 2019 |

Analyst: G1 Minimizes the Carnage of Chemotherapy

ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA. In a June 26 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on G1 Therapeutics Inc. (GTHX:NASDAQ) with a Buy ...
Streetwise Reports | July 2, 2020 |

Bob Moriarty's Thoughts on the Coronavirus

If there was ever a time for real leaders to step forward and lead, the last four months would have been the time to do so. If there was an issue that demanded cooperation from all the nations of the world, we have seen it. Instead we have been fed a steady diet of disinf...
Streetwise Reports | April 20, 2020 |
1 2 3 4 5 6 7 8 9 10 ...